(c) 2024 PillSync.com

malarone atovaquone and proguanil hydrochloride tablet film coated

1 INDICATIONS AND USAGE MALARONE is an antimalarial indicated for: • prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. ( 1.1 ) • treatment of acute, uncomplicated P. falciparum malaria. ( 1.2 ) 1.1 Prevention of Malaria MALARONE is indicated for the prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. 1.2 Treatment of Malaria MALARONE is indicated for the treatment of acute, uncomplicated P. falciparum malaria. MALARONE has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.

glaxosmithkline llc


5 years ago ROUND PINK GX CM3 malarone atovaquone and proguanil hydrochloride tablet film coated

ROUND PINK GX CM3

5 years ago ROUND PINK GX CM3 malarone atovaquone and proguanil hydrochloride tablet film coated

GX CM3 ROUND PINK

16 HOW SUPPLIED/STORAGE AND HANDLING MALARONE tablets, containing 250 mg atovaquone and 100 mg proguanil hydrochloride. • Bottle of 100 tablets with child-resistant closure (NDC 0173-0675-01). • Unit Dose Pack of 24 tablets with child-resistant lid foil (NDC 0173-0675-02). MALARONE pediatric tablets, containing 62.5 mg atovaquone and 25 mg proguanil hydrochloride. • Bottle of 100 tablets with child-resistant closure (NDC 0173-0676-01). Storage Conditions Store at 25°C (77°F). Temperature excursions are permitted to 15° to 30°C (59° to 86°F) (see USP Controlled Room Temperature).


More pills like ROUND GX CM3












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site